PathogenAR vs Schol
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
PathogenAR
Explore interactive stories about infectious diseases in augmented reality. This educational app uses touch gestures or a Merge Cube to bring pathogens to life, offering an engaging way to learn about disease.
- Augmented Reality exploration
- Interactive pathogen stories
- Touch gesture controls
- Merge Cube device compatibility
- Educational disease content
Read full descriptionHide full description
PathogenAR is an Augmented Reality application from the National Institute for Allergy and Infectious Diseases (NIAID). Explore interactive stories about pathogens and pathogenic disease using touch gestures or a Merge Cube Device.
Schol
View scientific data and information overlaid onto the real world using augmented reality. Point your device's camera at scientific content like papers or posters to access associated data, enhancing scientific communication.
- Augmented reality data visualization
- Integrates with scientific papers
- Enhances scientific communication
- Works with posters and articles
- Seamless content integration
Read full descriptionHide full description
Schol-AR enables the viewing of scientific data and information through augmented reality. Simply aim your mobile camera with Schol-AR open at various scientific content to view associated data. By enabling seamless integration of scientific papers, posters, books, articles and more we hope to dramatically improve modern scientific communication.
Screenshots
Verdict
The clearest difference is ratings volume: PathogenAR at 15 against Schol's 3. On price, rating, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for PathogenAR against 5.0 for Schol. That said, the two scores are not equally well evidenced: PathogenAR has 15 ratings behind it against 3, so its average is the more settled of the two.
PathogenAR ships an update every 2 months, Schol every 5 weeks. Both last shipped on September 16, 2026.
| Parameter | PathogenAR | Schol |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (15 ratings) | 5.0 (3 ratings) |
| Number of ratings | 15 — better | 3 |
| Update frequency | Every 2 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 | 12.0 |
| Further details — not scored | ||
| Size | 137 MB | 88 MB |
| Age rating | 4+ | 4+ |
| Developer | National Institute of Allergy and Infectious Diseases | Ardist Inc. |
Customer experience
PathogenAR
Schol
In-app purchases
PathogenAR
No in-app purchases
Schol
No in-app purchases
